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Abstract 
 
Heat Shock Protein 27 (Hsp27) is overexpressed in cervical cancer as a response to 
stress conditions. Hsp27 overexpression increase invasion, migration, and adhesion pathways 
of cancer cells. The Yogurt supernatant contains Short-Chain Fatty Acids (SCFA) include 
acetate, lactate, and butyrate which have anticancer activity. This study aimed to investigate 
supernatant of LBA-ST (Lactobacillusbulgaricus-acidophilus, Streptococcusthermophillus) Yogurt 
can decrease the expression of Hsp27 in HeLa culture cells. The mechanism on how 
supernatant yogurt inhibit invasion, migration, and adhesion was studied by 
immunocytochemistry. The data was then collected and analyzed using One-Way ANOVA. 
From this study, it can be concluded that the expression of proteins that play a role in 
invasion, adhesion, and migration of the Hsp27 was proven to be decreased (p< 0.05±0.005). 
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INTRODUCTION 
 
The growth of abnormal cells in 
mucosal servix, exocervix, and endocervix 
known as cervical cancer (American Cancer 
Society, 2012). Cervical cancer has the second 
highest prevalence of cancer in woman 
following breast cancer. Human papilloma 
virus (HPV) is the main cause in cervical 
cancer (Castellsagué, 2012). 
Vaccination, surgery, radiotherapy, and 
chemotherapy are the common therapies in the 
cervical cancer. Those therapies has serious 
side effects, and promising solution has not 
been established yet. Moreover, vaccination 
still can not be implemented in every country 
because of the high cost and limited availability 
(Goldie, et al., 2005).  
The fermentation products are 
recommended as the alternative therapy 
(Rahman, 2013), because of their multiple 
mechanisms of action, high safety, and the 
continuity of production (McFarldan, 2009). 
Yogurt is the product obtained from the milk 
fermentation by the lactic acid bateria. Short-
Chain Fatty Acids (SCFAs) such as butyrate, 
acetate, and lactate are the dominant metabolite 
compound in yogurt Lactobacillus bulgaricus-
acidophillus and Streptococcus thermophillus 
(LBA-ST) and were reported to have anticancer 
activity (Hara and Fergus, 2007).  
Those metabolites could have 
antimutagenic, antioxidative, and  
anticarcinogenic effect, along with the 
modulation of immune system (Wollowski, et 
al., 2001). In the identification of cervical 
cancer marker, Hsp27 is known as the critical 
role in the development of invasion, migration, 
and cell adhesion (Patel, et al., 2002; Rerole, et 
al., 2010) This study aim was to investigate 
LBA-ST yogurt supernatant in the decrease of 
Hsp27 expression on HeLa culture cells to 
inhibit the invasion, migration, and adhesion. 
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MATERIALS AND METHODS 
 
Fermentation of LBA – ST Yogurt 
(Lactobacillusbulgaricus-acidophilus, 
Streptococcusthermophillus) 
One litre of milk was heated in the 
temperature of 82-100ºC. Then the temperature 
was cooled down to 42-44ºC. As many as 5 gr 
of yogurt stater (yoguormet t.m) containing 
LBA-ST were dissolved in a cup of the milk 
and then homogenized well by adding a litre of 
milk. Incubation were done in the temperature 
of 4ºC for 4.5 hours or untill the pH reach 4-5. 
Fermentation was then stopped by storing the 
yogurt in the refrigerator prior to usage 
(Yogourmet, 2014). 
 
Preparation of supernatant, pellet, and 
whole LBA-ST yogurt 
As many as four falcons of 50 mL LBA-
ST Yogurt were centrifuged for 15 minutes in 
4000 rpm. The supernatant were separated from 
the bacteria pellet by filtration with Whatman 
paper. The storage were done in the 
temperature of  4ºC. 
 
HeLa Cell Culture    
HeLa cells were obtained from 
Laboratorium Pengujian dan Penelitian 
Terpadu (LPPT), Universitas Gadjah Mada, 
Yogyakarta. HeLa cells were cultured in RPMI 
1640 media supplemented with 10% (v/v) FBS 
and non essential amino acids. Cells were 
counted by haemocytometer. Cells were 
harvested with Trypsin-EDTA,  and centrifuged 
in 1500 rpm for 8 minutes. The supernatant was 
removed and the pellet was resuspended in the 
added culture media. Cells were cultured in 
well plates and were incubated in the 
temperature of 37C, 5% CO2, and 100% 
humidity. 
 
Hsp27 Immunocytochemistry 
As many as 5 x 10
4
 cells/1000 μL HeLa 
cells supension were cultured with RPMI 1640 
culture media and distributed in 24-well plate 
on the cover slips and incubated for 24 hours. 
After the cells were confluent, cells were 
treated by the supernatant of LBA-ST yogurt 
with the concentration of 10, 20, and 40% (v/v). 
As for the control group, 1000 μL of culture 
medium was added.  
After 24 hours incubation, the cover slips 
were washed by cold PBS 2 times, fixed by 
cold methanol for 15 minutes, and washed by 
the PBS once. Then the hydrogen peroxide as 
the blocking solution was added, followed by 
incubation for 10 minutes. The 
immunocytochemistry was done by adding 400 
μL Hsp27 monoclonal antibody in 1:200 
dilution. The incubation was done for 1 hour, 
then the cover slips were washed by the PBS. 
Biotinylated universal secondary antibody was 
then added. PBS were used to wash the cells 
before and after the incubation by streptavidin 
peroxidase enzyme. The incubation was done 
for 10 minutes. The chromogene substrate 
diaminobenzidine were added, continued with 
incubation for 10 minutes. Next, cells were 
washed by aquadest. As the counterstain, 
Meyer haematoxylin was added prior to 
incubation for 3 minutes, followed by washing 
using aquadest. The coverslips were then dried 
up by xylol and ethanol. The coverslips were 
placed on the microscope slides and mounted 
with entellan. Cells were observed and the 
Hsp27 expression were counted using the 
microscope. 
 
Data Analysis 
The data were analyzed statistically by 
the SPSS 16 for Windows 7 program. The 
normality and homogenity study were done 
first, and the analysis of the data were done by 
ANOVA (p = 0.05 and α = 0.05). 
 
RESULTS AND DISCUSSION 
 
The effects of LBA-ST yogurt 
supernatant to the expression of Hsp27 
The  aim  of this study was to investigate  
the  effects  of  LBA-ST  yoghurt   in  the  
decrease of Hsp27 expression on HeLa cells. 
The entire result of this  study showed that 
LBA-ST  yoghurt  has  anticancer  on  HeLa 
cells.  Anticancer activity showed by the data of 
the expression of Hsp27 in the Control cells 
(Fig. 1)  and  the  Hsp27  expression  index  by 
the treatment of LBA-ST yoghurt supernatant 
(Fig. 2). 
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Figure 1. The expression of Hsp27 in the control cells (A), the treatment of supernatant of 10% (v/v) 
(B), 20% (v/v) (C), and 40% (v/v) (D) LBA-ST yogurt. Incubation was done for 24 hours, and  the 
expression of Hsp27 in cells lead to the increase of the quantity of color and morphological changes in 
HeLa cells (400x magnification), decreased expression (      ), overexpression (        ). Distribution of 
cells and different cell sizes were obtained in the same magnification.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Hsp27 expression index by the treatment of LBA – ST yogurt supernatant in the 
concentration of 10%, 20%, dan 40% (v/v) compared to the control. The graph of reduction in 
Hsp27 expression were done by the data analysis by ANOVA (p<0.05 ± 0.005). 
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The testing of the anticancer 
mechanism in the cervical cancer can be done 
by the observation of Hsp27 expression. In this 
study, Hsp27 expression in HeLa cells were 
decreased by the treatment of supernatan of 
yogurt LBA significantly compared to the 
control (p<0.001). The highest reduction of 
Hsp27 expression was obtained by the 
treatment of supernatan of yogurt LBA in the 
concentration of 20% (v/v). Based on the result 
of this study, LBA-ST yogurt supernatant may 
inhibit the proliferation, migration, and invasion 
of cervical cancer cells, and also induce 
apoptosis. 
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